Skip to main content
Caplight Logo









Dynomics

Dynomics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.dynomics.com/

Last Round

VC Round

Aug 17, 2022

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Dynomics is a biotechnology company that has developed a human cardiac tissue discovery platform, HeartDyno®, to identify novel drug targets, new therapeutics, and target patient populations for precision cardiology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

drug discovery platformcardiac drug discoverycardiac organoidsheart-on-a-chipAI drug discoveryheart failure therapiesorgan-on-a-chipAI for biologyprecision medicinepreclinical modelsAAV gene therapysmall molecule discoverymulti-omics integrationpharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dynomics Comparables

Compare Dynomics with similar companies based on industry and business-model similarity.

Dynomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeartBeat.bio AG
87%
Genome Biologics
83%
Medera
81%

Dynomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 17, 2022

Key People

Founding team and executive leadership

Brendan Griffen

Chief Technology Officer & Co-Founder

Founding Team

Drew Titmarsh

CEO And Co-founder

Founding Team

Dynomics Investors

Notable investors and investment history

Dynomics investors
InvestorRounds
VSC VenturesVC Round
Boost VCVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 67% MoM, from 702 to 1.2K.

  • Nov 11, 2025

    Monthly visitors grew 453% MoM, reaching 873.

Dynomics Filings

Explore SEC and related filing metadata, where available.

Dynomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dynomics's valuation, stock price, and market status.

Is Dynomics a public or private company?

Dynomics is a private company.

What is the current stock price of Dynomics?

Dynomics is a private company with no public stock price. No recent secondary market data is available.

How much is Dynomics worth (valuation)?

Valuation information for Dynomics is not publicly available.

Can I buy Dynomics stock?

Dynomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dynomics's last funding round?

Dynomics's most recent funding round was VC Round on August 17, 2022.

Who are the main investors in Dynomics?

Key investors in Dynomics include VSC Ventures, Boost VC.

Will Dynomics IPO soon?

No public IPO plans have been announced for Dynomics.

How can I track Dynomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dynomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year FoundedN/A
Last FundingAug 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?